Conversation between a clinical biologist and an artificial intelligence on prostate cancer biomarkers: a critical reading.

Artificial intelligence is increasingly used in the field of medicine as a diagnostic aid, particularly for image analysis and more generally for data processing. Many artificial intelligence-based tools have been specifically developed for clinical biology, but some more general ones can help to improve the dissemination of medical knowledge. To test whether and to what extent an automated conversation tool could answer questions on a clinical biology topic (i.e. prostate cancer biomarkers), we questioned ChatGPT, an artificial intelligence-powered model dedicated to optimize language models for dialogue. Then we analyzed its responses.